Hematology Reports (Sep 2019)

Osteopontin expression and its relationship with prognostic factors in diffuse large B-cell lymphoma

  • Gilberto Barranco,
  • Edith Fernández,
  • Silvia Rivas,
  • Roxana Quezada,
  • Dolores Nava,
  • José Aguilar,
  • Abelardo García,
  • Horacio Astudillo,
  • Carmen Lome,
  • Erika Ruiz

DOI
https://doi.org/10.4081/hr.2019.7964
Journal volume & issue
Vol. 11, no. 3

Abstract

Read online

The aim of this study is to explore the expression of osteopontin (OPN) and its relationship with prognostic factors and survival in diffuse large B cell lymphoma (DLBCL). A tissue microarray was performed for immunohistochemical evaluation. Contingency tables were analyzed for trends; chi-square test was used to determine differences between groups. Univariate and multivariate Cox proportional hazards-regression analyses were performed to evaluate the impact of prognostic factors on survival. Expression of OPN was observed in 28%. It was different in non-germinal center DLBCL (P=0.04). The mean overall survival (OS) was lower in patients with positive OPN expression (19.762; CI 95% 14.269-25.255) it was not significant (P=0.123). It is not possible to establish a clear relationship between the expression by immunohistochemistry of osteopontin and a poor prognosis but it would be important to complement the analysis with other techniques as PCR or NGS that allow us to assess the influence of the isoforms and post-translational modifications of OPN on the biological behavior of DLBCL. Our findings indicate that OPN expression could be associated with a more aggressive variant of lymphoma: non-germinal center DLBCL.

Keywords